Effects of tenoxicam, a new anti-inflammatory drug, on in vitro neutrophil activation
Laghi Pasini, F.; Capecchi, P.L.; Ceccatelli, L.; Orrico, A.; Pasqui, A.L.; Di Perri, T.
Bollettino Chimico Farmaceutico 124(11): 477-482
1985
ISSN/ISBN: 0006-6648 PMID: 3833264 Document Number: 264784
Document emailed within 1 workday
Related Documents
Gallo, C.; Vighi, G.; Schroeder, J. 1987: Tenoxicam, a new long-acting non-steroidal anti-inflammatory drug. a placebo-controlled multicenter study La Clinica Terapeutica 120(5): 405-414Bennett, M.; Mitchell, S.; Dominguez, A. 2003: Adjunctive treatment of decompression illness with a non-steroidal anti-inflammatory drug (tenoxicam) reduces compression requirement Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 30(3): 195-205
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Arase, S.; Nagai, R.; Nakanishi, H.; Takeda, K. 1988: Effects of six topical corticosteroids on DNA synthesis of normal human skin fibroblasts--in vitro evaluation of anti-proliferative possibly anti-inflammatory potencies of corticosteroids Tokushima Journal of Experimental Medicine 35(1-2): 1-4
Kim, M.H.; Yoo, D.S.; Lee, S.Y.; Byeon, S.E.; Lee, Y.G.; Min, T.; Rho, H.S.; Rhee, M.H.; Lee, J.; Cho, J.Y. 2011: The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects Die Pharmazie 66(4): 293-300
Rainsford, K.D. 1985: Effects of anti-inflammatory drugs on catabolin-induced cartilage destruction in vitro International Journal of Tissue Reactions 7(2): 123-126
Franchimont, P.; Gysen, P.; Lecomte-Yerna, M.J.; Gaspar, S. 1983: In vitro incorporation of radioactive sulfur into proteoglycans of cartilage. Effects of various nonsteroidal anti-inflammatory agents Revue du Rhumatisme et des Maladies Osteo-Articulaires 50(4): 249-253
Amanuma, F.; Okuyama, S.; Orikasa, S.; Hashimoto, S.; Yamada, C.; Sakagawa, T.; Tsutsui, Y.; Tarumoto, Y.; Aihara, H.; Kameyama, T. 1984: The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(4): 345-354
He, Y.; Revel, M.; Loty, B. 1995: A quantitative model of post-laminectomy scar formation. Effects of a nonsteroidal anti-inflammatory drug Spine 20(5): 557-63; Discussion 579-80
Di Perri, T.; Laghi Pasini, F.; Capecchi, P.L.; Ceccatelli, L.; Pasqui, A.L.; Orrico, A. 1987: Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism International Journal of Tissue Reactions 9(5): 399-406
Van Hoogmoed, L.; Rakestraw, P.C.; Snyder, J.R.; Harmon, F.A. 1999: In vitro effects of nonsteroidal anti-inflammatory agents and prostaglandins I2, E2, and F2alpha on contractility of taenia of the large colon of horses American Journal of Veterinary Research 60(8): 1004-1009
Hasçelik, G.; Sener, B.; Hasçelik, Z. 1994: Effect of some anti-inflammatory drugs on human neutrophil chemotaxis Journal of International Medical Research 22(2): 100-106
de Rossi, L.W.; Horn, N.A.; Buhre, W.; Gass, F.; Hutschenreuter, G.; Rossaint, R. 2002: The effect of isoflurane on neutrophil selectin and beta(2)-integrin activation in vitro Anesthesia and Analgesia 95(3): 583-7 Table of Contents
Roubal, Z.; Grimová, J.; Nĕmecek, O.; Cepelák, V. 1972: Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro Acta Universitatis Carolinae. Medica. Monographia 53: 229-235
Tervaert, J.W.; Stegeman, C.A.; Brouwer, E.; Mulder, A.H.; Limburg, P.C.; Kallenberg, C.G. 1994: Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders Netherlands Journal of Medicine 45(6): 262-272
Goldfarb, R. 2002: Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may effect neutrophil activation Critical Care Medicine 30(1): 254-255
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Sakai, C.; Miura, R.; Shibata, A. 1987: Activation of neutrophil alkaline phosphatase of chronic myelogenous leukemia in vitro liquid culture: transferrin as a NAP-activating factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(3): 582-588
Hahn, A.B.; Soloski, M.J. 1989: Anti-Qa-2-induced T cell activation. the parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells Journal of Immunology 143(2): 407-413